The Valley Desk

ArticleJAMAPublished

Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
JAMA
Published
Subject terms
Humans; Drugs, Generic; Insurance Coverage; United States; Medicare Part D; Formularies as Topic; Biosimilar Pharmaceuticals; Adalimumab
PubMed ID
38842823
PubMed Central ID
PMC11157442
Added to directory
Source checked

Report a correction or request removal